Treatment outcome in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study (ESOS)

Ariane L. Herrick*, Xiaoyan Pan, Sébastien Peytrignet, Mark Lunt, Roger Hesselstrand, Luc Mouthon, Alan Silman, Edith Brown, László Czirják, Jörg H.W. Distler, Oliver Distler, Kim Fligelstone, William J. Gregory, Rachel Ochiel, Madelon Vonk, Codrina Ancuta, Voon H. Ong, Dominique Farge, Marie Hudson, Marco Matucci-CerinicAlexandra Balbir-Gurman, Øyvind Midtvedt, Alison C. Jordan, Paresh Jobanputra, Wendy Stevens, Pia Moinzadeh, Frances C. Hall, Christian Agard, Marina E. Anderson, Elisabeth Diot, Rajan Madhok, Mohammed Akil, Maya H. Buch, Lorinda Chung, Nemanja Damjanov, Harsha Gunawardena, Peter Lanyon, Yasmeen Ahmad, Kuntal Chakravarty, Søren Jacobsen, Alexander J. MacGregor, Neil McHugh, Ulf Müller-Ladner, Gabriela Riemekasten, Michael Becker, Janet Roddy, Patricia E. Carreira, Anne Laure Fauchais, Eric Hachulla, Jennifer Hamilton, Murat Inanç, John S. McLaren, Jacob M. Van Laar, Sanjay Pathare, Susannah Proudman, Anna Rudin, Joanne Sahhar, Brigitte Coppere, Christine Serratrice, Tom Sheeran, Douglas J. Veale, Claire Grange, Georges Selim Trad, Christopher P. Denton

*Corresponding author for this work
49 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Treatment outcome in early diffuse cutaneous systemic sclerosis: The European Scleroderma Observational Study (ESOS)'. Together they form a unique fingerprint.

Medicine & Life Sciences